Belite Bio Inc

NASDAQ: BLTE · Real-Time Price · USD
65.20
1.78 (2.81%)
At close: Aug 21, 2025, 3:59 PM
65.20
0.00%
After-hours: Aug 21, 2025, 04:10 PM EDT

Belite Bio Inc Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 May 31, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-54.31M -47.19M -40M -35.49M -36.72M -33.12M -31.67M -31.43M -23.01M -18.65M -12.82M -8.6M -8.56M -8.45M -9.8M -9.11M -8.43M -7.09M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 3.50 7.00 7.00 7.00 3.50 n/a n/a n/a n/a n/a n/a
Pretax Income
-49.38M -42.55M -36.14M -33.03M -35.28M -32.6M -31.62M -31.42M -22.89M -18.47M -12.65M -8.34M -8.41M -8.38M -9.67M -9.01M -8.36M -7.06M
Net Income
-49.38M -42.55M -36.14M -33.03M -35.29M -32.61M -31.63M -31.43M -22.89M -18.36M -12.55M -8.24M -8.31M -8.39M -9.67M -9.01M -8.36M -7.06M
Selling & General & Admin
19.77M 14.62M 10.06M 7.95M 7.27M 7.23M 6.82M 6.23M 5.36M 4.93M 3.95M 3.07M 2.32M 1.97M 2.38M 2.2M 2.02M 2.04M
Research & Development
34.54M 32.57M 29.94M 27.55M 29.45M 25.89M 24.84M 25.21M 17.65M 13.71M 8.87M 5.53M 6.24M 6.48M 7.42M 6.91M 6.41M 5.05M
Other Expenses
n/a n/a n/a n/a n/a 62K 54K 54K 54K -8K n/a 31.5K 31.5K 63K 94.5K 63K 63K 31.5K
Operating Expenses
54.31M 47.19M 40M 35.49M 36.72M 33.12M 31.67M 31.43M 23.01M 18.65M 12.82M 8.57M 8.51M 8.36M 9.67M 9.02M 8.37M 7.05M
Interest Expense
n/a n/a n/a n/a n/a n/a 8K 40.75K 40.75K 40.75K 49.75K 17.5K 17.5K 17.5K 500.00 5.25K 10.5K 15.75K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
54.31M 47.19M 40M 35.49M 36.72M 33.12M 31.67M 31.43M 23.01M 18.65M 12.82M 8.57M 8.51M 8.36M 9.67M 9.02M 8.37M 7.05M
Income Tax Expense
n/a n/a 6K 5K 6K 9K 9K 42.75K 41.74K -76.26K -65.26K -98.01K -98K 17K n/a 250.00 500.00 1K
Shares Outstanding (Basic)
32.59M 32.08M 31.45M 30.69M 30.32M 29.68M 28.32M 27.32M 25.79M 20.95M 22.42M 24.87M 19.66M 24.1M 9.57M 9.57M 9.57M 9.57M
Shares Outstanding (Diluted)
32.59M 32.08M 31.45M 30.69M 30.32M 29.68M 28.32M 27.32M 25.79M 20.95M 22.42M 24.87M 19.66M 24.1M 9.57M 9.57M 9.57M 9.57M
EPS (Basic)
-1.54 -1.35 -1.18 -1.11 -1.23 -1.18 -1.24 -1.29 -0.99 -0.85 -0.56 -0.52 -0.69 -0.82 -1.02 -0.97 -0.92 -0.79
EPS (Diluted)
-1.54 -1.35 -1.18 -1.11 -1.23 -1.18 -1.24 -1.29 -0.99 -0.85 -0.56 -0.52 -0.69 -0.82 -1.02 -0.97 -0.92 -0.79
EBITDA
-52.99M -47.11M -39.88M -35.33M -36.54M -32.96M -31.53M -31.37M -22.96M -18.6M -12.78M -8.57M -8.53M -8.42M -9.77M -9.09M -8.41M -7.07M
EBIT
-49.16M -43.31M -36.12M -35.49M -36.72M -33.12M -31.67M -31.25M -22.82M -18.46M -12.63M -8.6M -8.56M -8.45M -9.8M -9.11M -8.43M -7.09M
Depreciation & Amortization
118.75K 153.5K 146.25K 195.25K 176.5K 157.75K 139K 64K 55.5K 47K 38.5K 30K 30K 30K 30K 27K 24K 20.5K